Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

C. A.S. Arndt, A. G. Nascimento, G. Schroeder, P. J. Schomberg, J. P. Neglia, S. F. Sencer, T. L. Silberman, C. L. Moertel, J. K. Tillisch, J. S. Miser

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide'. Together they form a unique fingerprint.

Medicine & Life Sciences